{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T07:13:06Z","timestamp":1788592386668,"version":"build-2803163510"},"reference-count":85,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.numecd.2026.104805","type":"journal-article","created":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T00:38:44Z","timestamp":1779583124000},"page":"104805","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Associations between lipid parameters and incident cardio-renal-metabolic multimorbidity: The Tehran Lipid and Glucose Study"],"prefix":"10.1016","volume":"36","author":[{"given":"Soroush","family":"Masrouri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navid","family":"Ebrahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danial","family":"Molavizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzad","family":"Esmaeili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereidoun","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8935-2744","authenticated-orcid":false,"given":"Farzad","family":"Hadaegh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.numecd.2026.104805_bib1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41572-022-00376-4","article-title":"Multimorbidity","volume":"8","author":"Skou","year":"2022","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.numecd.2026.104805_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101860","article-title":"Global and regional prevalence of multimorbidity in the adult population in community settings: a systematic review and meta-analysis","volume":"57","author":"Chowdhury","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"4","key":"10.1016\/j.numecd.2026.104805_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-057017","article-title":"Variation in the estimated prevalence of multimorbidity: systematic review and meta-analysis of 193 international studies","volume":"12","author":"Ho","year":"2022","journal-title":"BMJ Open"},{"issue":"24","key":"10.1016\/j.numecd.2026.104805_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph192416502","article-title":"Prevalence of multimorbidity in the Middle East: a systematic review of observational studies","volume":"19","author":"Singh","year":"2022","journal-title":"Int J Environ Res Publ Health"},{"issue":"16","key":"10.1016\/j.numecd.2026.104805_bib5","doi-asserted-by":"crossref","first-page":"e840","DOI":"10.1161\/CIR.0000000000000664","article-title":"Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American heart association","volume":"139","author":"Rangaswami","year":"2019","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.numecd.2026.104805_bib6","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-kidney-metabolic health: a presidential advisory from the American heart association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.numecd.2026.104805_bib7","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s12916-021-02126-x","article-title":"Association between cardiometabolic disease multimorbidity and all-cause mortality in 2 million women and men registered in UK general practices","volume":"19","author":"Canoy","year":"2021","journal-title":"BMC Med"},{"issue":"20","key":"10.1016\/j.numecd.2026.104805_bib8","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","article-title":"A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American heart association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.numecd.2026.104805_bib9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1001\/jama.2015.7008","article-title":"Association of cardiometabolic multimorbidity with mortality","volume":"314","author":"Di Angelantonio","year":"2015","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.numecd.2026.104805_bib10","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41569-021-00541-4","article-title":"Global epidemiology of dyslipidaemias","volume":"18","author":"Pirillo","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.numecd.2026.104805_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-511X-9-85","article-title":"Lipid ratios and appropriate cut off values for prediction of diabetes: a cohort of Iranian men and women","volume":"9","author":"Hadaegh","year":"2010","journal-title":"Lipids Health Dis"},{"issue":"1","key":"10.1016\/j.numecd.2026.104805_bib12","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1186\/s12967-023-04509-5","article-title":"Understanding the relationship between circulating lipids and risk of chronic kidney disease: a prospective cohort study and large-scale genetic analyses","volume":"21","author":"Wang","year":"2023","journal-title":"J Transl Med"},{"key":"10.1016\/j.numecd.2026.104805_bib13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.atherosclerosis.2020.03.020","article-title":"Association of blood lipid profile with incident chronic kidney disease: a Mendelian randomization study","volume":"300","author":"Zhang","year":"2020","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.numecd.2026.104805_bib14","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2337\/dc16-1958","article-title":"Triglyceride and HDL-C dyslipidemia and risks of coronary heart disease and ischemic stroke by glycemic dysregulation status: the strong heart Study","volume":"40","author":"Lee","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2026.104805_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1280185","article-title":"Serum\/plasma biomarkers and the progression of cardiometabolic multimorbidity: a systematic review and meta-analysis","volume":"11","author":"Jin","year":"2023","journal-title":"Front Public Health"},{"issue":"5","key":"10.1016\/j.numecd.2026.104805_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0300740","article-title":"Genetic effects and causal association analyses of 14 common conditions\/diseases in multimorbidity patterns","volume":"19","author":"Fu","year":"2024","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.numecd.2026.104805_bib17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12863-021-00968-1","article-title":"Association between apolipoprotein gene polymorphisms and hyperlipidemia: a meta-analysis","volume":"22","author":"Zhao","year":"2021","journal-title":"BMC Genomic Data"},{"key":"10.1016\/j.numecd.2026.104805_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103953","article-title":"Lipid traits and type 2 diabetes risk in African ancestry individuals: a Mendelian Randomization study","volume":"78","author":"Soremekun","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.numecd.2026.104805_bib19","doi-asserted-by":"crossref","DOI":"10.1177\/2235042X20961919","article-title":"Multimorbidity of chronic non-communicable diseases in low-and middle-income countries: a scoping review","volume":"10","author":"Abebe","year":"2020","journal-title":"J Comorb"},{"issue":"2","key":"10.1016\/j.numecd.2026.104805_bib20","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13661","article-title":"Determinants of multimorbidity in low\u2010and middle\u2010income countries: a systematic review of longitudinal studies and discovery of evidence gaps","volume":"25","author":"Tan","year":"2024","journal-title":"Obes Rev"},{"key":"10.1016\/j.numecd.2026.104805_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-511X-9-6","article-title":"Lipid measures for prediction of incident cardiovascular disease in diabetic and non-diabetic adults: results of the 8.6 years follow-up of a population based cohort study","volume":"9","author":"Tohidi","year":"2010","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.numecd.2026.104805_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1745-6215-10-5","article-title":"Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and glucose study phase II","volume":"10","author":"Azizi","year":"2009","journal-title":"Trials"},{"key":"10.1016\/j.numecd.2026.104805_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-511X-9-52","article-title":"A modified formula for calculating low-density lipoprotein cholesterol values","volume":"9","author":"Chen","year":"2010","journal-title":"Lipids Health Dis"},{"issue":"19","key":"10.1016\/j.numecd.2026.104805_bib24","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine-and cystatin C\u2013based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2026.104805_bib25","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00592-011-0298-5","article-title":"Fasting glucose cutoff point: where does the risk terminate? Tehran lipid and glucose study","volume":"49","author":"Bozorgmanesh","year":"2012","journal-title":"Acta Diabetol"},{"issue":"1","key":"10.1016\/j.numecd.2026.104805_bib26","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2023.2216020","article-title":"Predictors of decline in kidney function in the general population: a decade of follow-up from the Tehran Lipid and Glucose Study","volume":"55","author":"Masrouri","year":"2023","journal-title":"Ann Med"},{"issue":"3","key":"10.1016\/j.numecd.2026.104805_bib27","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41371-025-01107-4","article-title":"Blood pressure and renal function decline in apparently healthy adults: the tehran lipid and glucose study","volume":"40","author":"Ebrahimi","year":"2026","journal-title":"J Hum Hypertens"},{"issue":"24","key":"10.1016\/j.numecd.2026.104805_bib28","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1001\/jama.2014.6634","article-title":"Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality","volume":"311","author":"Coresh","year":"2014","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.numecd.2026.104805_bib29","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1053\/j.ajkd.2014.08.017","article-title":"GFR decline as an alternative end point to kidney failure in clinical trials: a meta-analysis of treatment effects from 37 randomized trials","volume":"64","author":"Inker","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"4 Suppl","key":"10.1016\/j.numecd.2026.104805_bib30","article-title":"Outcomes of a longitudinal population-based cohort study and pragmatic community trial: findings from 20 years of the Tehran Lipid and glucose study","volume":"16","author":"Khalili","year":"2018","journal-title":"Int J Endocrinol Metabol"},{"issue":"8","key":"10.1016\/j.numecd.2026.104805_bib31","doi-asserted-by":"crossref","first-page":"e587","DOI":"10.1016\/S2468-2667(21)00107-9","article-title":"Examining variation in the measurement of multimorbidity in research: a systematic review of 566 studies","volume":"6","author":"Ho","year":"2021","journal-title":"Lancet Public Health"},{"issue":"1","key":"10.1016\/j.numecd.2026.104805_bib32","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s12933-024-02347-3","article-title":"Lifestyle factors and their relative contributions to longitudinal progression of cardio-renal-metabolic multimorbidity: a prospective cohort study","volume":"23","author":"Zhang","year":"2024","journal-title":"Cardiovasc Diabetol"},{"issue":"11","key":"10.1016\/j.numecd.2026.104805_bib33","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1001\/jamacardio.2023.3241","article-title":"Prevalence and overlap of cardiac, renal, and metabolic conditions in US adults, 1999-2020","volume":"8","author":"Ostrominski","year":"2023","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.numecd.2026.104805_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2023.163406","article-title":"Ambient air pollution and incidence, progression to multimorbidity and death of hypertension, diabetes, and chronic kidney disease: a national prospective cohort","volume":"881","author":"Wu","year":"2023","journal-title":"Sci Total Environ"},{"issue":"12","key":"10.1016\/j.numecd.2026.104805_bib35","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1111\/dom.14829","article-title":"Interconnection between cardiovascular, renal and metabolic disorders: a narrative review with a focus on Japan. Diabetes","volume":"24","author":"Kadowaki","year":"2022","journal-title":"Obes Metabol"},{"issue":"3","key":"10.1016\/j.numecd.2026.104805_bib36","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2007.01.002","article-title":"Multiple risk factors for cardiovascular disease and diabetes mellitus","volume":"120","author":"Smith","year":"2007","journal-title":"Am J Med"},{"issue":"14","key":"10.1016\/j.numecd.2026.104805_bib37","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa2206916","article-title":"Global effect of modifiable risk factors on cardiovascular disease and mortality","volume":"389","author":"Magnussen","year":"2023","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.numecd.2026.104805_bib38","doi-asserted-by":"crossref","first-page":"3A","DOI":"10.1016\/j.amjcard.2009.10.007","article-title":"Cardiovascular disease risk factors: epidemiology and risk assessment","volume":"105","author":"Dahl\u00f6f","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.numecd.2026.104805_bib39","series-title":"Incidence of chronic kidney disease and its risk factors, results of over 10 year follow up in an Iranian cohort","author":"Tohidi","year":"2012"},{"issue":"1","key":"10.1016\/j.numecd.2026.104805_bib40","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.diabres.2014.01.002","article-title":"Prevalence, trends and risk factors for the diabetes epidemic in China: a systematic review and meta-analysis","volume":"104","author":"Zuo","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"10.1016\/j.numecd.2026.104805_bib41","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/EDE.0b013e3181a819a1","article-title":"Overadjustment bias and unnecessary adjustment in epidemiologic studies","volume":"20","author":"Schisterman","year":"2009","journal-title":"Epidemiology"},{"issue":"3","key":"10.1016\/j.numecd.2026.104805_bib42","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10654-019-00494-6","article-title":"Principles of confounder selection","volume":"34","author":"VanderWeele","year":"2019","journal-title":"Eur J Epidemiol"},{"issue":"12","key":"10.1016\/j.numecd.2026.104805_bib43","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","article-title":"A simulation study of the number of events per variable in logistic regression analysis","volume":"49","author":"Peduzzi","year":"1996","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"10.1016\/j.numecd.2026.104805_bib44","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/aje\/kwk052","article-title":"Relaxing the rule of ten events per variable in logistic and Cox regression","volume":"165","author":"Vittinghoff","year":"2007","journal-title":"Am J Epidemiol"},{"issue":"446","key":"10.1016\/j.numecd.2026.104805_bib45","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"issue":"2","key":"10.1016\/j.numecd.2026.104805_bib46","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/(SICI)1097-0258(19980130)17:2<219::AID-SIM735>3.0.CO;2-O","article-title":"Methods for interval\u2010censored data","volume":"17","author":"Lindsey","year":"1998","journal-title":"Stat Med"},{"issue":"5","key":"10.1016\/j.numecd.2026.104805_bib47","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1080\/10543406.2013.813524","article-title":"A review of statistical issues with progression-free survival as an interval-censored time-to-event endpoint","volume":"23","author":"Sun","year":"2013","journal-title":"J Biopharm Stat"},{"issue":"1","key":"10.1016\/j.numecd.2026.104805_bib48","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/0962280209105023","article-title":"Interval censoring","volume":"19","author":"Zhang","year":"2010","journal-title":"Stat Methods Med Res"},{"issue":"1","key":"10.1016\/j.numecd.2026.104805_bib49","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.pcd.2014.03.007","article-title":"Meta-analysis of Atherogenic index of plasma and other lipid parameters in relation to risk of type 2 diabetes mellitus","volume":"9","author":"Zhu","year":"2015","journal-title":"Prim Care Diabetes"},{"issue":"6","key":"10.1016\/j.numecd.2026.104805_bib50","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1053\/j.ajkd.2015.05.011","article-title":"Impact of the triglycerides to high-density lipoprotein cholesterol ratio on the incidence and progression of CKD: a longitudinal Study in a large Japanese population","volume":"66","author":"Tsuruya","year":"2015","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1016\/j.numecd.2026.104805_bib51","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/eurheartj\/eht571","article-title":"Mendelian randomization of blood lipids for coronary heart disease","volume":"36","author":"Holmes","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2026.104805_bib52","article-title":"Non-HDL cholesterol and residual risk of cardiovascular events in patients with ischemic heart disease and well-controlled LDL cholesterol: a cohort study","volume":"36","author":"Hansen","year":"2024","journal-title":"Lancet Reg Health Eur"},{"issue":"2","key":"10.1016\/j.numecd.2026.104805_bib53","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/lipd.12337","article-title":"Lipid profile, lipid ratios, apolipoproteins, and risk of cardiometabolic multimorbidity in men: the Kuopio Ischaemic Heart disease risk factor study","volume":"57","author":"Tajik","year":"2022","journal-title":"Lipids"},{"key":"10.1016\/j.numecd.2026.104805_bib54","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.maturitas.2020.04.016","article-title":"Multimorbidity in a cohort of middle-aged women: risk factors and disease clustering","volume":"137","author":"Bl\u00fcmel","year":"2020","journal-title":"Maturitas"},{"issue":"3","key":"10.1016\/j.numecd.2026.104805_bib55","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ejim.2015.02.012","article-title":"Clinical and lifestyle-related risk factors for incident multimorbidity: 10-year follow-up of Finnish population-based cohorts 1982\u20132012","volume":"26","author":"Wikstr\u00f6m","year":"2015","journal-title":"Eur J Intern Med"},{"issue":"12","key":"10.1016\/j.numecd.2026.104805_bib56","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1001\/jama.2012.366","article-title":"Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis","volume":"307","author":"Boekholdt","year":"2012","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.numecd.2026.104805_bib57","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.diabres.2013.07.009","article-title":"Impact of low-density lipoprotein cholesterol on cardiovascular outcomes in people with type 2 diabetes: a meta-analysis of prospective cohort studies","volume":"102","author":"Wang","year":"2013","journal-title":"Diabetes Res Clin Pract"},{"issue":"32","key":"10.1016\/j.numecd.2026.104805_bib58","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European atherosclerosis society consensus panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.numecd.2026.104805_bib59","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1472-8206.2009.00739.x","article-title":"Lipid modification in type 2 diabetes: the role of LDL and HDL","volume":"23","author":"Verges","year":"2009","journal-title":"Fund Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.numecd.2026.104805_bib60","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/01.CIR.82.2.495","article-title":"Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk","volume":"82","author":"Austin","year":"1990","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.numecd.2026.104805_bib61","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.numecd.2021.09.037","article-title":"Low-density lipoprotein cholesterol levels and adverse clinical outcomes in chronic kidney disease: results from the KNOW-CKD","volume":"32","author":"Lee","year":"2022","journal-title":"Nutr Metabol Cardiovasc Dis"},{"issue":"10215","key":"10.1016\/j.numecd.2026.104805_bib62","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/S0140-6736(19)32519-X","article-title":"Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the multinational cardiovascular risk consortium","volume":"394","author":"Brunner","year":"2019","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.numecd.2026.104805_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/nu14183792","article-title":"Non-High-Density lipoprotein cholesterol and cardiovascular outcomes in chronic kidney disease: results from KNOW-CKD study","volume":"14","author":"Suh","year":"2022","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.numecd.2026.104805_bib64","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12933-019-0851-z","article-title":"Serum triglycerides as a risk factor for cardiovascular diseases in type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies","volume":"18","author":"Ye","year":"2019","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.numecd.2026.104805_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-018-0692-1","article-title":"Association between triglyceride glucose index and arterial stiffness in Korean adults","volume":"17","author":"Lee","year":"2018","journal-title":"Cardiovasc Diabetol"},{"issue":"1 Pt 2","key":"10.1016\/j.numecd.2026.104805_bib66","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1161\/01.HYP.35.1.303","article-title":"Insulin inhibits migration of vascular smooth muscle cells with inducible nitric oxide synthase","volume":"35","author":"Kahn","year":"2000","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.numecd.2026.104805_bib67","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s12882-020-01907-5","article-title":"The association between dyslipidemia and the incidence of chronic kidney disease in the general Zhejiang population: a retrospective study","volume":"21","author":"Liang","year":"2020","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.numecd.2026.104805_bib68","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s12519-019-00270-2","article-title":"Impact of dyslipidemia on estimated glomerular filtration rate in apparently healthy children and adolescents: the CASPIAN-V study","volume":"15","author":"Moafi","year":"2019","journal-title":"World Journal of Pediatrics"},{"issue":"2","key":"10.1016\/j.numecd.2026.104805_bib69","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.atherosclerosis.2014.12.013","article-title":"Subclinical carotid atherosclerosis and triglycerides predict the incidence of chronic kidney disease in the Japanese general population: results from the Kyushu and Okinawa Population Study (KOPS)","volume":"238","author":"Shimizu","year":"2015","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.numecd.2026.104805_bib70","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1053\/j.jrn.2017.05.002","article-title":"Association of hypertriglyceridemia with the incidence and progression of chronic kidney disease and modification of the association by daily alcohol consumption","volume":"27","author":"Tsuruya","year":"2017","journal-title":"J Ren Nutr"},{"issue":"1","key":"10.1016\/j.numecd.2026.104805_bib71","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2023.2216020","article-title":"Predictors of decline in kidney function in the general population: a decade of follow-up from the Tehran Lipid and Glucose study","volume":"55","author":"Masrouri","year":"2023","journal-title":"Ann Med"},{"issue":"1","key":"10.1016\/j.numecd.2026.104805_bib72","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1038\/s41467-024-46686-x","article-title":"Elevated blood remnant cholesterol and triglycerides are causally related to the risks of cardiometabolic multimorbidity","volume":"15","author":"Zhao","year":"2024","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.numecd.2026.104805_bib73","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.numecd.2026.104805_bib74","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1107579","article-title":"Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy","volume":"365","author":"Boden","year":"2011","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.numecd.2026.104805_bib75","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa1300955","article-title":"Effects of extended-release niacin with laropiprant in high-risk patients","volume":"371","author":"Landray","year":"2014","journal-title":"N Engl J Med"},{"issue":"9841","key":"10.1016\/j.numecd.2026.104805_bib76","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(12)60312-2","article-title":"Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study","volume":"380","author":"Voight","year":"2012","journal-title":"Lancet"},{"issue":"32","key":"10.1016\/j.numecd.2026.104805_bib77","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European atherosclerosis society consensus panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.numecd.2026.104805_bib78","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/EDE.0000000000000409","article-title":"Selection bias due to loss to follow up in cohort studies","volume":"27","author":"Howe","year":"2016","journal-title":"Epidemiology"},{"issue":"4","key":"10.1016\/j.numecd.2026.104805_bib79","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/HCO.0000000000000740","article-title":"Measuring LDL-cholesterol: what is the best way to do it?","volume":"35","author":"Wolska","year":"2020","journal-title":"Curr Opin Cardiol"},{"issue":"4","key":"10.1016\/j.numecd.2026.104805_bib80","first-page":"282","article-title":"Methods of low-density lipoprotein-cholesterol measurement: analytical and clinical applications","volume":"33","author":"Islam","year":"2022","journal-title":"EJIFCC"},{"issue":"1","key":"10.1016\/j.numecd.2026.104805_bib81","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1186\/1756-0500-4-308","article-title":"Simple parametric survival analysis with anonymized register data: a cohort study with truncated and interval censored event and censoring times","volume":"4","author":"St\u00f8vring","year":"2011","journal-title":"BMC Res Notes"},{"issue":"4","key":"10.1016\/j.numecd.2026.104805_bib82","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s43441-024-00640-7","article-title":"Improvement of midpoint imputation for estimation of median survival time for interval-censored time-to-event data","volume":"58","author":"Nakagawa","year":"2024","journal-title":"Therapeutic Innovation & Regulatory Science"},{"issue":"9","key":"10.1016\/j.numecd.2026.104805_bib83","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1007\/s00125-012-2616-z","article-title":"Age at menarche and risk of type 2 diabetes among African-American and white women in the Atherosclerosis Risk in Communities (ARIC) study","volume":"55","author":"Dreyfus","year":"2012","journal-title":"Diabetologia"},{"issue":"9","key":"10.1016\/j.numecd.2026.104805_bib84","first-page":"985","article-title":"Association of cardiovascular health and time lived with zero coronary artery calcium","volume":"18","author":"Shah","year":"2025","journal-title":"Cardiovascular Imaging"},{"issue":"5","key":"10.1016\/j.numecd.2026.104805_bib85","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1080\/10543406.2013.813524","article-title":"A review of statistical issues with progression-free survival as an interval-censored time-to-event endpoint","volume":"23","author":"Sun","year":"2013","journal-title":"J Biopharm Stat"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093947532600267X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093947532600267X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T07:03:44Z","timestamp":1788591824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S093947532600267X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":85,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S093947532600267X"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2026.104805","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations between lipid parameters and incident cardio-renal-metabolic multimorbidity: The Tehran Lipid and Glucose Study","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2026.104805","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104805"}}